XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert S. who wrote (16874)	5/23/2004 9:09:56 AM
From: Robert K.	Read Replies (1) of 17367

Mycoprex. I am STILL scratching my head on why this one isnt in development. I STILL think the product has all that potential. Only thing I can figure is they couldnt get to an acceptable oral version, and thats what the market wants. I would be very excited to see the company step back to the plate. If xoma doesnt then someone like the chinese will. Cacaito >Regarding ING-1, you said the product is dead, I cant confirm or deny that, but I have heard that they need to run 5-10k patients in a ing trial and xoma cant go that alone. Why would they need so many in trial if thats true? Also been wondering if chiron would step up to the plate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next